Extract from the Register of European Patents

EP About this file: EP0823889

EP0823889 - 1,3-PROPANE DIOL DERIVATIVES AS BIOACTIVE COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.07.2003
Database last updated on 28.03.2026
Most recent event   Tooltip25.07.2003No opposition filed within time limitpublished on 10.09.2003  [2003/37]
Applicant(s)For all designated states
Scarista Limited
Victoria House 26 Victoria Street Douglas
Isle of Man / GB
[N/P]
Former [2002/26]For all designated states
Scarista Limited
Victoria House 26 Victoria Street Douglas
Isle of Man / GB
Former [1998/08]For all designated states
SCOTIA HOLDINGS PLC
Weyvern House, Weyvern Park, Portsmouth Road, Peasmarsh
Guildford, Surrey GU3 1NA / GB
Inventor(s)01 / HORROBIN, David F., Scotia Pharmaceuticals Ltd
Efamol House, Woodbridge Meadows
Guildford, Surrey GU1 1BA / GB
02 / MANKU, Mehar, Scotia Pharmaceuticals Ltd.
R&DCtr, Kingstown Ind. Est., Kingstown Broadway
Carlisle CA3 0HA / GB
03 / MCMORDIE, Austin, Scotia Pharmaceuticals Ltd
R&D CCtr, Kingstown Ind. Est., Kingstown Broadway
Carlisle CA3 0HA / GB
04 / KNOWLES, Philip, Scotia Pharmaceuticals Ltd
R&D Ctr, Kingstown Ind. Est., Kingstown Broadway
Carlisle CA3 0HA / GB
05 / REDDEN, Peter, Efamol Res. Inc., Unit 2
Annapolis Ind. Est., Chapman Drive, P.O. Box 818
Kentville, Novia Scotia B4N 4H8 / CA
06 / PITT, Andrea, Scotia Pharmaceuticals Ltd
R&D Ctr, Kingstown Ind. Est., Kingstown Broadwayay
Carlisle CA3 0HA / GB
07 / BRADLEY, Paul, Scotia Pharmaceuticals Ltd
R&D Ctr, Kingstown Ind. Est., Kingstown Broadway
Carlisle CA3 0HA / GB
08 / WAKEFIELD, Paul, Scotia Pharmaceuticals Ltd
R&D Ctr, Kingstown Ind. Est., Kingstown Broadway
Carlisle CA3 0HA / GB
[1998/08]
Representative(s)Wakerley, Helen Rachael, et al
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2002/26]Wakerley, Helen Rachael, et al
Reddie & Grose, 16 Theobalds Road
London WC1X 8PL / GB
Former [1998/08]Farwell, William Robert, et al
PHILLIPS & LEIGH 7 Staple Inn High Holborn
London WC1V 7QF / GB
Application number, filing date96912139.101.05.1996
[1998/08]
WO1996GB01053
Priority number, dateGB1995000882301.05.1995         Original published format: GB 9508823
GB1995001710721.08.1995         Original published format: GB 9517107
GB1996000544015.03.1996         Original published format: GB 9605440
[1998/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9634846
Date:07.11.1996
Language:EN
[1996/49]
Type: A1 Application with search report 
No.:EP0823889
Date:18.02.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 07.11.1996 takes the place of the publication of the European patent application.
[1998/08]
Type: B1 Patent specification 
No.:EP0823889
Date:18.09.2002
Language:EN
[2002/38]
Search report(s)International search report - published on:EP07.11.1996
ClassificationIPC:C07C69/587, C07D339/04, C07F9/00, C07D233/94, C07D213/68, C07D213/67, A61K31/44
[1998/08]
CPC:
C07D213/30 (EP,US); C07D209/28 (EP,KR,US); A61K31/23 (KR,US);
A61P1/00 (EP); A61P11/00 (EP); A61P13/02 (EP);
A61P15/00 (EP); A61P17/00 (EP); A61P25/00 (EP);
A61P25/08 (EP); A61P25/14 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/26 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P27/02 (EP); A61P27/14 (EP);
A61P29/00 (EP); A61P3/02 (EP); A61P3/08 (EP);
A61P31/04 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P9/08 (EP); A61P9/10 (EP);
C07C69/007 (EP,US); C07C69/16 (US); C07C69/587 (EP,US);
C07C69/76 (EP,US); C07D213/66 (EP,US); C07D233/94 (EP,US);
C07D279/36 (EP,US); C07D321/00 (EP,US); C07D339/04 (EP,KR,US);
C07D499/00 (EP,US); C07F9/091 (EP,US); C07F9/65522 (EP,US);
C07J1/0059 (EP,US); C07J5/0053 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1998/08]
Extension statesLT22.10.1997
LV22.10.1997
SI22.10.1997
TitleGerman:1,3-PROPANDIOL-DERIVATE ALS BIOAKTIVE VERBINDUNGEN[1998/08]
English:1,3-PROPANE DIOL DERIVATIVES AS BIOACTIVE COMPOUNDS[1998/08]
French:DERIVES DE 1,3-PROPANEDIOL UTILISES COMME COMPOSES BIOACTIFS[1998/08]
Entry into regional phase22.10.1997National basic fee paid 
22.10.1997Designation fee(s) paid 
22.10.1997Examination fee paid 
Examination procedure20.11.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.10.1997Examination requested  [1998/08]
15.12.1998Despatch of a communication from the examining division (Time limit: M04)
16.03.1999Reply to a communication from the examining division
14.04.1999Despatch of a communication from the examining division (Time limit: M04)
26.04.1999Reply to a communication from the examining division
28.07.1999Despatch of a communication from the examining division (Time limit: M06)
21.01.2000Reply to a communication from the examining division
07.08.2000Despatch of a communication from the examining division (Time limit: M04)
25.11.2000Reply to a communication from the examining division
20.03.2001Despatch of communication of intention to grant (Approval: Yes)
16.11.2001Despatch of communication that the application is refused, reason: formalities examination {1}
04.02.2002Communication of intention to grant the patent
09.05.2002Fee for grant paid
09.05.2002Fee for publishing/printing paid
Opposition(s)19.06.2003No opposition filed within time limit [2003/37]
Request for further processing for:15.01.2002Request for further processing filed
15.01.2002Full payment received (date of receipt of payment)
Request granted
04.02.2002Decision despatched
Fees paidRenewal fee
04.05.1998Renewal fee patent year 03
07.05.1999Renewal fee patent year 04
13.04.2000Renewal fee patent year 05
03.05.2001Renewal fee patent year 06
14.05.2002Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X] JPS5767511  
 [X]   F.L. BREUSCH ET AL.: "Darstellung der di-, tri- und tetra-homologen Reihen der Methan-methylol-fettsureester", CHEMISCHE BERICHTE, vol. 88, 1955, WEINHEIM DE, pages 1511 - 1519, XP002009215 [X] 1-24 * the whole document *
 [X]   CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 July 1987, Columbus, Ohio, US; abstract no. 23659p, I. WATANABE ET AL.: "Preparation and formulation of orally active aminoglycoside antibiotics." page 648; XP002009216 [X] 1-6,9,16,22,24 * abstract *
 [X]   PATENT ABSTRACTS OF JAPAN vol. 6, no. 143 (C - 117) 3 August 1982 (1982-08-03) [X] 1-6,9,16,21,22,24 * abstract *
 [X]   CHEMICAL ABSTRACTS, vol. 95, no. 5, 3 August 1981, Columbus, Ohio, US; abstract no. 41676e, M. VAJDI ET AL.: "GC/MS analysis of some long chain esters, ketones and propanediol diesters" page 641; XP002009217 [X] 1-6,9,16,22,24 * abstract *
 [X]   JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 58, no. 2, 1981, CHAMPAIGN US, pages 106 - 110
 [X]   CHEMICAL ABSTRACTS, vol. 92, no. 1, 7 January 1980, Columbus, Ohio, US; abstract no. 461a, P. LANGEN ET AL.: "Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogen analogs of long chain acyl- and alkylglycerols" page 48; XP002009218 [X] 1-12,14-18,20,22-24 * abstract *
 [X]   ACTA BIOLOGICA ET MEDICA GERMANICA, vol. 38, no. 7, 1979, BERLIN, pages 965 - 974
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.